You may have heard about the Inflation Reduction Act or changes regarding the Medicare program’s ability to negotiate prescription drug prices. Join me as I host fellow colleagues for a discussion about what these changes mean for you.
CSC’s Cancer Policy Institute our 5th annual Summit on Utilization Management, showcasing two panels of experts:
Panel I discussed the impact of the Inflation Reduction Act (IRA) on patient access and emphasized the importance of patient engagement in healthcare policy decision-making, showcasing discussions from the following experts:
- Sara van Geertruyden, JD – Executive Director, Partnership to Improve Patient Care
- Barry Liden – Director of Public Policy, USC Schaeffer Center
- Michael Ward, MS – VP Public Policy & Government Relations, Alliance for Aging Research
